Cargando…

Donor-derived cell-free DNA detects kidney transplant rejection during nivolumab treatment

BACKGROUND: In solid organ transplant (SOT) recipients, transplant rejection during immune checkpoint inhibitor (ICI) treatment for cancer is a clinical problem. Donor-derived cell-free DNA (dd-cfDNA) can be detected in blood and is a sensitive biomarker for diagnosis of acute rejection in SOT recip...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hurkmans, Daan P., Verhoeven, Jeroen G. H. P., de Leur, Kitty, Boer, Karin, Joosse, Arjen, Baan, Carla C., von der Thüsen, Jan H., van Schaik, Ron H. N., Mathijssen, Ron H. J., van der Veldt, Astrid A. M., Hesselink, Dennis A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6626432/ https://www.ncbi.nlm.nih.gov/pubmed/31300068 http://dx.doi.org/10.1186/s40425-019-0653-6

Ejemplares similares

Donor-Derived Cell-Free DNA for the Detection of Heart Allograft Injury: The Impact of the Timing of the Liquid Biopsy
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2022)

Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients
por: Bins, Sander, et al.
Publicado: (2018)

Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy
por: de With, Mirjam, et al.
Publicado: (2021)

CD45RA(+)CCR7(−) CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab
por: Kunert, Andre, et al.
Publicado: (2019)

Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study
por: Verhoeven, Jeroen G. H. P., et al.
Publicado: (2021)

A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients
por: Hurkmans, Daan P., et al.
Publicado: (2019)

Suitability of tumor-associated antibodies as predictive biomarker for response to immune checkpoint inhibitors in patients with melanoma: a short report
por: de Joode, Karlijn, et al.
Publicado: (2023)

Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer
por: Hurkmans, Daan P., et al.
Publicado: (2020)

Tumor mutational load, CD8(+) T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients
por: Hurkmans, Daan P., et al.
Publicado: (2020)

Alloreactive T cells to Assess Acute Rejection Risk in Kidney Transplant Recipients
por: Mendoza Rojas, Aleixandra, et al.
Publicado: (2023)

Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma
por: Hurkmans, Daan P, et al.
Publicado: (2020)

Prospective real-world study on the pharmacokinetics of pembrolizumab in patients with solid tumors
por: Hurkmans, Daan P., et al.
Publicado: (2021)

A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients
por: Oosten, Astrid W., et al.
Publicado: (2016)

CYP3A4(∗)22 Genotyping in Clinical Practice: Ready for Implementation?
por: Mulder, Tessa A. M., et al.
Publicado: (2021)

Polyfunctional donor-reactive T cells are associated with acute T-cell-mediated rejection of the kidney transplant
por: Litjens, Nicolle H R, et al.
Publicado: (2023)

CD16+ Monocytes and Skewed Macrophage Polarization toward M2 Type Hallmark Heart Transplant Acute Cellular Rejection
por: van den Bosch, Thierry P. P., et al.
Publicado: (2017)

Mast Cells in Kidney Transplant Biopsies With Borderline T Cell-mediated Rejection and Their Relation to Chronicity
por: Varol, Hilal, et al.
Publicado: (2023)

Individualization of Irinotecan Treatment: A Review of Pharmacokinetics, Pharmacodynamics, and Pharmacogenetics
por: de Man, Femke M., et al.
Publicado: (2018)

Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen
por: Hussaarts, Koen G.A.M., et al.
Publicado: (2019)

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy
por: Mulder, Tessa A. M., et al.
Publicado: (2021)

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer: Outcomes of Cardio-Oncology Follow-Up
por: Pruis, Melinda A., et al.
Publicado: (2023)

Variations in DNA methylation of interferon gamma and programmed death 1 in allograft rejection after kidney transplantation
por: Boer, Karin, et al.
Publicado: (2016)

T Follicular Helper Cells As a New Target for Immunosuppressive Therapies
por: Yan, Lin, et al.
Publicado: (2017)

Immunomics of Renal Allograft Acute T Cell-Mediated Rejection Biopsies of Tacrolimus- and Belatacept-Treated Patients
por: van der Zwan, Marieke, et al.
Publicado: (2018)

Feasibility and Potential of Transcriptomic Analysis Using the NanoString nCounter Technology to Aid the Classification of Rejection in Kidney Transplant Biopsies
por: Varol, Hilal, et al.
Publicado: (2022)

The mast cell: A Janus in kidney transplants
por: van der Elst, G., et al.
Publicado: (2023)

Corrigendum: The mast cell: A Janus in kidney transplants
por: van der Elst, G., et al.
Publicado: (2023)

The prognostic value of weight and body composition changes in patients with non‐small‐cell lung cancer treated with nivolumab
por: Degens, Juliette H.R.J., et al.
Publicado: (2021)

Loss of CD28 on Peripheral T Cells Decreases the Risk for Early Acute Rejection after Kidney Transplantation
por: Dedeoglu, Burç, et al.
Publicado: (2016)

Comparison of Alemtuzumab and Anti-thymocyte Globulin Treatment for Acute Kidney Allograft Rejection
por: van der Zwan, Marieke, et al.
Publicado: (2020)

Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis
por: ten Berge, Deirdre M.H.J., et al.
Publicado: (2019)

IL-21 Receptor Antagonist Inhibits Differentiation of B Cells toward Plasmablasts upon Alloantigen Stimulation
por: de Leur, Kitty, et al.
Publicado: (2017)

The Efficacy of Rabbit Anti-Thymocyte Globulin for Acute Kidney Transplant Rejection in Patients Using Calcineurin Inhibitor and Mycophenolate Mofetil-Based Immunosuppressive Therapy
por: van der Zwan, Marieke, et al.
Publicado: (2018)

6. Dose Adjustments Based on Pharmacogenetics of CYP450 Enzymes
por: van Schaik, Ron H.N.
Publicado: (2008)

Circulating endothelial cells transiently increase in peripheral blood after kidney transplantation
por: Tejeda-Mora, H., et al.
Publicado: (2021)

Clinical and Molecular Profiling to Develop a Potential Prediction Model for the Response to Alemtuzumab Therapy for Acute Kidney Transplant Rejection
por: Hullegie‐Peelen, Daphne M., et al.
Publicado: (2022)

Oncological healthcare providers’ perspectives on appropriate melanoma survivorship care: a qualitative focus group study
por: Kamminga, Nadia C. W., et al.
Publicado: (2023)

Antitumor activity of nivolumab on hemodialysis after renal allograft rejection
por: Ong, Michael, et al.
Publicado: (2016)

Plasma Predictive Features in Treating EGFR-Mutated Non-Small Cell Lung Cancer
por: Steendam, Christi M. J., et al.
Publicado: (2020)

Experiences of resuming life after immunotherapy and associated survivorship care needs: a qualitative study among patients with metastatic melanoma
por: Kamminga, Nadia C.W., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bktt1nt3apjsr3hk49qfbgonm7